BeOne Medicines
ONC
#857
Rank
NZ$50.62 B
Marketcap
NZ$487.98
Share price
1.59%
Change (1 day)
13.91%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2026 (TTM): NZ$8.25

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is NZ$8.50. In 2025 the company made an earnings per share (EPS) of NZ$4.82 an increase over its 2024 EPS that were of NZ-$11.03.

EPS history for BeOne Medicines from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$8.2570.97%
2025NZ$4.82-143.75%
2024NZ-$11.03
2022NZ-$34.4628.21%
2021NZ-$26.88-19.96%
2020NZ-$33.5820.81%
2019NZ-$27.8031.52%
2018NZ-$21.14417.57%
2017NZ-$4.08-37.16%
2016NZ-$6.50158.95%
2015NZ-$2.51

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
NZ-$0.42-104.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
NZ-$1.68-119.75%๐Ÿ‡บ๐Ÿ‡ธ USA